Electroporation Apparatus and Methods Patent Application
Summary
The USPTO has published a patent application (US20260085268A1) filed by MaxCyte, Inc. on September 6, 2023. The application describes an apparatus and methods for electroporation of cells, including safety features like an emergency stop button. This is a new patent application and does not impose new regulatory requirements.
What changed
The United States Patent and Trademark Office (USPTO) has published a new patent application, US20260085268A1, filed by MaxCyte, Inc. The application details an apparatus and methods for electroporation of cells, focusing on a system that includes a high voltage module, a low voltage module with a user interface, and a single board computer. A key feature highlighted is an electronic circuit designed to receive, latch, and process signals from an emergency stop button to safely terminate voltage application and disable processor commands to the high voltage module.
This publication represents a new patent application and does not constitute a final rule or guidance with immediate compliance obligations. However, companies involved in cell therapy, drug development, or medical device manufacturing, particularly those utilizing electroporation technology, should be aware of this filing. The assignee, MaxCyte, Inc., is a known entity in this space, and the patent's claims, if granted, could impact future product development and intellectual property landscapes in the biotechnology and medical device sectors.
Source document (simplified)
APPARATUS AND METHODS FOR ELECTROPORATION
Application US20260085268A1 Kind: A1 Mar 26, 2026
Assignee
MaxCyte, Inc.
Inventors
Sergey Mikhailovych DZEKUNOV, Nicholas CHOPAS, Stephen PORTER
Abstract
An apparatus and methods for electroporation of cells are disclosed. The apparatus comprises a memory storing instructions, a high voltage module to apply a voltage to cells, a low voltage module including a user interface, a system board connected to the high voltage module, the low voltage module, and a single board computer, and the single board computer including at least one processor to control the high voltage module and the low voltage module. The system board includes an emergency stop button and an electronic circuit. The electronic circuit receives a signal from the emergency stop button, latches the signal from the emergency stop button, blocks a logical signal controlling the voltage delivered to the instrument output, terminates the voltage applied to cells, and disables the at least one processor to provide commands to the high voltage module.
CPC Classifications
C12M 35/02 C12M 41/48 C12N 13/00
Filing Date
2023-09-06
Application No.
19109342
Named provisions
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Pharma & Drug Safety alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when ChangeBridge: Patent Apps - Biotech (C12N) publishes new changes.